JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Down 6.1% in July

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) saw a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 380,200 shares, a decline of 6.1% from the July 15th total of 405,000 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 3,802.0 days.

JCR Pharmaceuticals Stock Performance

OTCMKTS:JCRRF opened at $4.30 on Wednesday. JCR Pharmaceuticals has a 52 week low of $4.30 and a 52 week high of $4.30. The stock’s fifty day moving average is $4.82 and its two-hundred day moving average is $5.58.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.